- E03.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E03.9 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E03.9 – other international versions of ICD-10 E03.9 may differ.
ICD-10-CM E03.9 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Myxedema NOS
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E03.9:
- myxedema > due to (in) (with) D64.81
- hypothyroidism NEC > in (due to) E22.0
- hypothyroidism > in (due to) E22.0
- myxedema > in G31.2
- in > systemic affecting central nervous system
- myxedema > in E03.9
- myxedema > Cataract (cortical) (immature) (incipient) H26.9
- myxedema > in G31.2
- hypothyroidism, acquired > in (due to) F10.97
- with behavioral disturbance > hypothyroidism, acquired E03.9
- thyroid (gland) (acquired) > Insufficiency, insufficient
- hypothyroidism > in (due to) E27.1
- myxedema > in (due to) E27.1